YEARS AND LIFE ( AS OBJECTIVE REALITY ) ON REGULAR HEMODIALYSIS

THE AIM of the investigation is an analysis of clinico(cid:2)laboratory and biophysical indices characterizing the metabolic shifts in chronic hemodialysis patients under continuous observation. PATIENTS AND METHODS. During 201 sessions of regular hemodialysis 108 patients with the terminal stage of CRF were examined. Repeated examinations were performed on 36 patients within 1.5 years after the observations were started, 22 patients were examined once more within 5.3 years. The level of parathyroid hormone in blood was determined in 59 patients. Reliability of differences in the data before and after the hemodialysis sessions (p<0.05) was estimated by the value of Student’s coefficient, the hemodialysis effectiveness (cid:2) by the value Kt/V. Survival of the patients was calculated by the moment unified methods. RESULTS. For the recent decade the average term of life of these patients has become two times longer. Positive dynamics was noted in the indices of the state of the cardio(cid:2)vascular system: the duration of hemodialysis treatment had negative correlation with systolic arterial pressure (r = (cid:2)0.246±0.070, p<0.001 before session; r = (cid:2)0.349±0.067, p<0.0001after session), diastolic arterial pressure (r = (cid:2)0.286±0.069, p<0.001 before session; r = (cid:2)0.340±0.068, p<0.0001after session), and pulse pressure after session (r = (cid:2) 0.293±0.069, p<0.0001). A correlation was established of the electrolyte status of plasma with the duration of hemodialysis treatment: Na + concentration before hemodialysis session decreased (r = (cid:2)0.232±0.070, p = 0.001), and Ca 2+ (cid:2) increased (r =(cid:2)0.327±0.068, p<0.0001). The increased intensity of protein metabolism was expressed as a gradually increased concentration of the total blood protein (r = 0.234±0.080, p = 0.001), albumin (r = 0.157±0.071, p= 0.028) and urea concentration in blood plasma (r = 0.229±0.070, p= 0.001). Dry weight of the patients decreased in due course (r = (cid:2)0.264±0.068, p <0.0001). Stability of the erythrocyte membranes grew up: acid hemolysis time shortened (r =(cid:2) 0.152±0.071, p=0.034 before session), hematocrit increased (r = 0.190±0.070, p=0.008 before session). Coefficients of correlation of arterial pressure with the patients’ weight before and after hemodialysis sessions are presented as well as with the concentration of Na + in blood plasma. Their sufficiently stable status was noted with the exception of the mineral metabolism indices. Even with the optimal values of the phosphorus(cid:2)calcium product activity of alkaline phosphatase becomes 60% higher for 8(cid:2)9 years of chronic hemodialysis treatment. An analysis of clinico(cid:2)laboratory indices disclosed the most possible mechanisms of impairments of the cardio(cid:2) vascular system, protein(cid:2)lipid metabolism, water(cid:2)electrolyte and nutritional status. The priority directions in correction are determined. CONCLUSION. In case of successful adaptation of the patient to regular hemodialysis treatment at the initial period his condition gradually becomes better in the following 2(cid:2)3 years, and later for 7(cid:2)9 years remains fairly stable. The high quality hemodialysis therapy effectively corrects the impaired protein and lipid metabolism, maintains nutritional status, adequately corrects anemia, and the cardio(cid:2)vascular system parameters do not deteriorate. The cellular structures become stable, the membrane systems improve. The state of mineral metabolism is the only thing that remains problematic.

[1]  Александра Александровна Яковенко,et al.  ЗНАЧЕНИЕ «ПОТЕНЦИАЛЬНО УРЕМИЧЕСКИХ ТОКСИНОВ» В РАЗВИТИИ НЕДОСТАТОЧНОСТИ ПИТАНИЯ У ГЕМОДИАЛИЗНЫХ БОЛЬНЫХ , 2008 .

[2]  Sándor Ferenczi,et al.  The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  Giuseppe Pontoriero,et al.  The quality of dialysis water. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  R. Suri,et al.  The impact of quotidian hemodialysis on nutrition. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  B. Čižman Hyperphosphataemia and treatment with sevelamer in haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  W. Clark,et al.  An operating cost comparison between conventional and home quotidian hemodialysis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  A. P. Heidenheim,et al.  The London Daily/Nocturnal Hemodialysis Study--study design, morbidity, and mortality results. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  G. Curhan,et al.  The association between mental health, physical function, and hemodialysis mortality. , 2003, Kidney international.

[9]  B. Bačić,et al.  Ultrafiltration Volume Is Associated with Changes in Blood Pressure in Chronically Hemodialyzed Patients , 2003, Renal failure.

[10]  A. Sehgal,et al.  The relative predictive ability of four different measures of hemodialysis dose. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  R. Foley,et al.  Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. , 2002, Kidney international.

[12]  D. di Lorenzo,et al.  Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients. , 2002, Journal of nephrology.

[13]  David W. Johnson,et al.  Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  X. Leverve,et al.  Malnutrition in hemodialysis diabetic patients: evaluation and prognostic influence. , 2002, Kidney international.

[15]  E. DeLong,et al.  Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. , 2002, JAMA.

[16]  Y. Berland,et al.  Water quality and complications of haemodialysis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[17]  K. Johansen,et al.  Vintage, nutritional status, and survival in hemodialysis patients. , 2000, Kidney international.

[18]  R. Wolfe,et al.  Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  K. Fukuoka,et al.  Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. , 1999, Clinical nephrology.

[20]  Shu-yi Wei,et al.  Red Blood Cell Osmotic Fragility in Chronically Hemodialyzed Patients , 1997, Nephron.

[21]  B. Fisch,et al.  Assessment of excess fluid distribution in chronic hemodialysis patients using bioimpedance spectroscopy. , 1996, Kidney international.

[22]  I. Varga,et al.  The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure , 1992, Pediatric Nephrology.

[23]  R B D'Agostino,et al.  Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. , 1990, The New England journal of medicine.

[24]  М Д Желязкова-Савова,et al.  Некарбоксилированный остеокальцин у женщин в постменопаузе, получающих лечение гемодиализом , 2011 .

[25]  В Н Спиридонов Расчет выживаемости в отделении гемодиализа , 2001 .

[26]  N. Matsuzawa [Studies on the relationship between serum albumin concentration and lipid peroxidation in the erythrocyte membrane of maintenance hemodialysis patients]. , 2001, Nihon Jinzo Gakkai shi.

[27]  Ю. А. Борисов,et al.  Кислотная, осмотическая и ультразвуковая резистентность эритроцитов больных, получающих лечение регулярным гемодиализом , 2000 .

[28]  G. Greca From pathophysiology to clinical hemodialysis at the beginning of the next millennium , 2000 .

[29]  F. Coronel,et al.  Heme biosynthesis in uremic patients on CAPD or hemodialysis. , 1994, Kidney international.

[30]  B. Charra,et al.  Survival in dialysis and blood pressure control. , 1994, Contributions to nephrology.

[31]  G. Ronquist,et al.  Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca. , 1994, Nephron.

[32]  T. Grune,et al.  Changed Purine Nucleotide Concentrations and Enzyme Activities in Erythrocytes of Haemodialysis Patients Undergoing Erythropoietin Therapy , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[33]  R. D'Agostino,et al.  Changes in risk factors and the decline in mortality from cardiovascular disease. , 1990, The New England journal of medicine.

[34]  Ю.С. Бородаев,et al.  Лабораторные методы исследования минералов, руд и пород , 1975 .